Feng Xue
Impact in
- Hepatology top 10%
- Hepatocellular Carcinoma Treatment and Prognosis
- Ophthalmology top 10%
- Retinal Diseases and Treatments
Papers in
- Oncology 10
- Lung Cancer Research Studies 3
- Hepatology 10
- Hepatocellular Carcinoma Treatment and Prognosis 10
- Co-authors
- Yanfu Sun (5 shared papers)Ming Yang (1 shared paper)Yanling Wang (1 shared paper)Jialin Wang (1 shared paper)Ning Dong (1 shared paper)Zhiling Liu (1 shared paper)Lei Hu (2 shared papers)Qingshi Zeng (1 shared paper)
- Journals
- Frontiers in Oncology (4 papers)Frontiers in Medicine (2 papers)World Journal of Gastroenterology (2 papers)Journal of Surgical Oncology (1 paper)International Journal of Surgery (1 paper)
- Partner nations
- ChinaUnited StatesAustralia
In The Last Decade
Feng Xue
45 papers receiving 385 citations
Peers
Comparison fields: 5 of 60
- Hepatology 96
- Ophthalmology 41
- Pathology and Forensic Medicine 42
- Radiology, Nuclear Medicine and Imaging 51
- Oncology 52
Countries citing papers authored by Feng Xue
This map shows the geographic impact of Feng Xue's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Feng Xue with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Feng Xue more than expected).
Fields of papers citing papers by Feng Xue
This network shows the impact of papers produced by Feng Xue. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Feng Xue. The network helps show where Feng Xue may publish in the future.
Co-authors
The 25 scholars most cited alongside Feng Xue, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 47 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 39 | |
| 2 | 2012 | 34 | |
| 3 | 2012 | 32 | |
| 4 | 2012 | 26 | |
| 5 | 2019 | 21 | |
| 6 | 2014 | 18 | |
| 7 | 2021 | 15 | |
| 8 | 2020 | 14 | |
| 9 | 2022 | 14 | |
| 10 | 2020 | 13 | |
| 11 | 2012 | 12 | |
| 12 | 2023 | 10 | |
| 13 | 2022 | 10 | |
| 14 | 2021 | 9 | |
| 15 | Glutamine synthetase predicts adjuvant TACE response in hepatocellular carcinoma. | 2015 | 9 |
| 16 | 2023 | 8 | |
| 17 | 2010 | 8 | |
| 18 | 2022 | 7 | |
| 19 | 2023 | 6 | |
| 20 | 2022 | 6 |
About Feng Xue
Feng Xue is a scholar working on Oncology, Hepatology, Surgery, Pulmonary and Respiratory Medicine and Epidemiology, having authored 47 papers that have together received 387 indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (10 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (6 papers), Endometrial and Cervical Cancer Treatments (3 papers), Lung Cancer Research Studies (3 papers), Lung Cancer Treatments and Mutations (3 papers), MRI in cancer diagnosis (2 papers), Ectopic Pregnancy Diagnosis and Management (2 papers) and Advanced Neuroimaging Techniques and Applications (2 papers). The work is most often cited by research in Hepatology (96 citations), Ophthalmology (41 citations), Pathology and Forensic Medicine (42 citations), Radiology, Nuclear Medicine and Imaging (51 citations) and Oncology (52 citations). Feng Xue has collaborated with scholars based in China, United States and Australia. Frequent co-authors include Yanfu Sun, Ming Yang, Yanling Wang, Jialin Wang, Ning Dong, Zhiling Liu, Lei Hu, Qingshi Zeng, Shilei Ni and Dong Wu. Their work appears in journals such as Frontiers in Oncology, Frontiers in Medicine, World Journal of Gastroenterology, Journal of Surgical Oncology and International Journal of Surgery.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.